Zimmer Biomet Holdings (ZBH) Tops Q1 EPS by 1c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Zimmer Biomet (ZBH) PT Raised to $127 at Canaccord Genuity
April 26, 2019 1:27 PM EDTCanaccord Genuity analyst Kyle Rose raised the price target on Zimmer Biomet (NYSE: ZBH) to $127.00 (from $125.00) while maintaining a Hold rating.
executing to plan but still early in the process... MoreZimmer Biomet (ZBH) PT Raised to $134 at RBC Capital
April 26, 2019 11:45 AM EDTRBC Capital analyst Brandon Henry raised the price target on Zimmer Biomet (NYSE: ZBH) to $134.00 (from $128.00) while maintaining a Outperform rating following results.
Long-Term Turnaround Story Unchanged;... MoreNeedham & Company Upgrades Zimmer Biomet (ZBH) to Strong Buy
April 24, 2019 6:06 AM EDTNeedham & Company analyst Mike Matson upgraded Zimmer Biomet (NYSE: ZBH) from Buy to Strong Buy with a price target of $155.00.
The analyst comments "We expect ZBHs revenue growth to accelerate during 2019 as it shifts back to offense after addressing its supply... More



